Valeant Pharmaceuticals International (VRX) - Investment Analysts' Recent Ratings Changes


They now have a "hold" rating on the stock. 8/10/2017 - Valeant Pharmaceuticals International had its "underperform" rating reaffirmed by analysts at Wells Fargo & Company.



from Biotech News